Innovent Biologics, Inc. (HKG:1801)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
84.60
-1.50 (-1.74%)
Oct 28, 2025, 4:08 PM HKT

Innovent Biologics Revenue

Innovent Biologics had revenue of 5.95B CNY in the half year ending June 30, 2025, with 120.36% growth. This brings the company's revenue in the last twelve months to 11.42B, up 53.18% year-over-year. In the year 2024, Innovent Biologics had annual revenue of 9.42B with 51.82% growth.

Revenue (ttm)
11.42B CNY
Revenue Growth
+53.18%
P/S Ratio
11.58
Revenue / Employee
2.02M CNY
Employees
5,659
Market Cap
144.96B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.42B3.22B51.82%
Dec 31, 20236.21B1.65B36.21%
Dec 31, 20224.56B286.65M6.71%
Dec 31, 20214.27B425.91M11.08%
Dec 31, 20203.84B2.80B266.94%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro